Skip to content

OSTYCUT® 17820050Recalls & reported problems

Angiomed GmbH & Co. Medizintechnik KG · OSTYCUT® Disposable Bone Biopsy Needles, 16g x 100mm · Class 1

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741083679), received between Jun 6, 2022 and Jun 6, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Break1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 6, 2022Break; Adverse Event Without Identified Device or Use Problem; Break; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT DURING A BONE BIOPSY PROCEDURE OF THE RIGHT CALCANEUM, THE BIOPSY MATERIAL ALLEGEDLY REMAINED IN THE BONE DURING REMOVAL. THERE WAS NO REPORTED PATIENT INJURY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14600219 ↗

Other NEEDLE, ASPIRATION AND INJECTION, DISPOSABLE devices

All NEEDLE, ASPIRATION AND INJECTION, DISPOSABLE devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page